Amgen (AMGN) Tax Provisions (2009 - 2026)

Amgen (AMGN) has reported Tax Provisions for 18 consecutive years, with $265.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Tax Provisions rose 9.05% year-over-year to $265.0 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 79.5% YoY), while the FY2025 annual figure was $1.3 billion, up 143.74% from the prior year.
• Tax Provisions came in at $265.0 million for Q1 2026 at Amgen, up from $181.0 million in the prior quarter.
• The five-year high for Tax Provisions was $705.0 million in Q3 2025, with the low at $45.0 million in Q1 2024.
• Average Tax Provisions over 5 years is $234.2 million, with a median of $214.0 million recorded in 2022.
• Across the five-year window, Tax Provisions plunged 92.51% in 2024 and jumped 440.0% in 2025, its largest moves.
• Year by year, Tax Provisions stood at $132.0 million in 2022, then sank by 35.61% to $85.0 million in 2023, then soared by 82.35% to $155.0 million in 2024, then grew by 16.77% to $181.0 million in 2025, then surged by 46.41% to $265.0 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $265.0 million, $181.0 million, and $705.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.